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Abstract We have used circular dichroism to study synthetic 
peptides from two important regions of the prion protein: the N-
terminal octa-repeat domain and a highly conserved hydrophobic 
section. Our results show that the octa-repeat sequence in free 
solution can adopt a non-random, extended conformation with 
properties similar to the poly-L-proline type II left-handed helix. 
We also show that the conformation can be changed by 
temperature, organic solvents (e.g. acetonitrile) and on binding 
to phospholipid vesicles. We compared CD data from two 
peptides corresponding to the hydrophobic region between 
residues 106 and 136 which contained either methionine or 
valine at position 129. This variation represents a common 
polymorphism in humans which has been shown to influence 
predisposition towards iatrogenic and sporadic CJD. There was 
no detectable difference between the CD spectra of these peptides 
irrespective of the solvent conditions we used. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The prion diseases are transmissible neurodegenerative con-
ditions which include Creutzfeldt-Jakob disease (CJD), Gerst-
mann-Straussler-Scheinker disease (GSS) and kuru in hu-
mans; and scrapie and bovine spongiform encephalopathy 
(BSE) in animals. Research interest in this area has been in-
tense because of the unique properties of the transmissible 
agent or prion. 
The nature of the prion has been the subject of strong 
debate for many years since, despite its infectious properties, 
no significant nucleic acid content has been found [1-6]. In-
stead, a wide body of data now supports the idea that the 
transmissible agent consists of an abnormal isoform of a host-
encoded sialoglycoprotein, the prion protein (PrP), designated 
prpSc ^ o r r e v j e w s e e reference [7]). In all the prion diseases 
PrPSc accumulates in affected brains and forms partially pro-
tease-resistant aggregates and sometimes amyloid deposits. 
The normal form of the protein, PrPc , is found predomi-
nantly on the surface of neurones, attached by a glycosylphos-
phatidylinositol (GPI) anchor [8-11]. It has therefore been 
suggested that it may have a role in cell adhesion or signalling. 
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There is little insight into its function although electrophysio-
logical studies in PrP-null mice have shown that PrP is neces-
sary for normal synaptic function [12]. 
prpSc ;s dgnved from PrP
c by a post-translational mecha-
nism [13-16]. Systematic study of known covalent post-trans-
lational modifications has shown no consistent differences be-
tween PrP c and PrPSc [17]. By exclusion, therefore, it has been 
assumed that the difference lies in a conformational change. 
Evidence for differences in secondary structure content be-
tween the two isoforms has been provided by circular dichro-
ism (CD) and Fourier transform infrared (FTIR) spectro-
scopic methods. These techniques show PrP c to be rich in 
oc-helix while PrPSc is seen to have a high P-sheet content [18]. 
The current model of prion propagation is that PrPSc inter-
acts directly with PrPc , promoting its conversion to additional 
prpSc [1920]. Such a pathogenic mechanism was originally 
proposed as a result of transgenetic and human molecular 
genetic studies which demonstrate the importance of PrP se-
quence identity for the initiation and progression of prion 
diseases [19,21-25]. The production of protease-resistant PrP 
from PrPc has now been shown in vitro although it has not 
yet been possible to demonstrate infectivity of the protease-
resistant form [26]. 
Recently a solution structure of a core region of mouse PrP 
corresponding to residues 121-231 has been determined [27]. 
However this does not include the N-terminal octa-repeat 
region of the protein and lacks part of the hydrophobic re-
gion. Here we report studies on these two unusual segments of 
polypeptide. Extensive human molecular genetic data indi-
cates that these regions are of key importance in the patho-
genesis of prion diseases. The first region consists of 4 glycine-
rich, tandemly repeating, octapeptide units following a non-
apeptide of related sequence. This sequence represents a 
unique structural motif, having no significant homology to 
other sequences in the protein database. Expansions of this 
region, by the insertion of additional integral numbers of tan-
dem octa-repeat elements, are seen in families with inherited 
prion diseases. Kindreds with an additional 2, 4, 5, 6, 7, 8, and 
9 octa-repeats have been described [28-34]. Conversely, dele-
tional mutations, deleting a single octa-repeat element, are 
non-pathogenic and are uncommon polymorphisms in the 
normal population [35,36]. Interestingly, comparison with 
chicken PrP, which shows an overall similarity of only around 
40%, [37,38] shows the chicken sequence to contain a series of 
tandem hexapeptide repeats at the same position in the se-
quence as the octapeptide repeats in mammalian species im-
plying an evolutionary requirement for somewhat similar re-
peating units across mammalian and avian species at this 
position. 
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200 YSIGPAAKKNTSEAVAAANQTEVEMENKWTKVIREMCVQQY.RE Y 244 
227 QRGSSMVLFSSPPVILLISFLIFLIVG*.. 254 
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Fig. 1. Comparison of human and chicken sequences using a Wis-
consin GCG alignment program. The percentage similarity was 59% 
and the percentage identity was 41%. Of particular note is the re-
gion of almost exact identity within the hydrophobic domain (resi-
dues 126-141 of the chicken sequence). Although there is no direct 
homology to the human octa-repeat region the chicken sequence 
contains an array of sexapeptide repeats at the same position. 
The second region we study is a hydrophobic region be-
tween residues 113 and 128 (in Fig. 1) which is totally con-
served across chicken and mammalian sequences presently 
known. Before experiments indicated that P r P c was releasable 
from the cell surface it was proposed that this formed a trans-
membrane helix [39-41]. The region has been predicted to be 
helical in the native protein while the recent N M R structure 
of the core section (residues 121-231) of mouse P rP shows 
that part of it forms a P strand. Short peptides produced 
corresponding to residues 106-126 have a number of interest-
ing properties in that they show amyloid-like features and are 
toxic to cultured neuronal cells [42,43]. Some of the following 
studies are based on the knowledge that individuals homozy-
gous for the common polymorphism of methionine or valine 
at codon 129, which falls within the region proposed to be a 
hydrophobic helix, are more likely to succumb to either iatro-
genic or the sporadic forms of prion disease [21]. This suggests 
that a highly specific interaction must take place between the 
infectious particle and the host reserve of P r P c and that the 
interaction is influenced by the presence of methionine or val-
ine at codon 129. 
Interestingly, a sub-type of inherited prion disease has been 
described with a point mutat ion in codon 145 resulting in a 
T y r - » S T O P change in the protein [44]. Affected individuals 
therefore express a truncated PrP which consists almost en-
tirely of the octa-repeat region and the hydrophobic sequence. 
This genetic evidence further highlights their functional im-
portance. 
2. Materials and methods 
2.1. Materials 
Triethanolamine hydrochloride was from Boehringer Mannheim, 
sodium chloride, acetic acid and sodium acetate, Analar grade and 
HPLC grade acetonitrile were from BDH Chemicals. Grade I egg 
lecithin and phosphatidylserine from bovine spinal cord were from 
Lipid Products, South Nutfleld, UK. 
2.2. Preparation of peptides 
The four peptides were synthesised by the Bristol University Peptide 
synthesis unit. The 16-residue octa-repeat peptide was acetylated at 
the N-terminus. The peptides were made on a Milligen 9050 auto-
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matic peptide synthesiser using Fmoc chemistry with HBTU (o-ben-
zotriazol-Ar,Ar,Af',A'''-tetra-methyl-uronium-hexafluoro-phosphate) ac-
tivation on a Milligen PEG-PS resin using customised protocols. 
Side-chain protection was as follows: trityl for Gin and His, ?-butyl 
for tyrosine and protonation for arginine. After completion of the 
synthesis the resin was washed with methanol and dichloromethane 
and dried under high vacuum overnight. Peptides were cleaved from 
the resin using TFA:ethanediol:anisole:H20 in the ratio 94:2:2:2 for 
2 h. The peptides were recovered by ether precipitation. The short (16-
residue) octa-repeat peptide was purified by HPLC to over 90% pu-
rity. Plasma desorption mass spectrometry was conducted on an Ap-
plied Biosystems Bio-Ion spectrometer and showed a major peak of 
molecular weight 1649. The long (46 residue) octa-repeat peptide was 
of sufficient purity (above 90%) to be used directly. Electrospray mass 
spectrometry performed on a VG Quattro spectrometer showed this 
peptide to be one major component of molecular weight 4481 ±0.64. 
The 31-residue 'hydrophobic' peptides were of sufficient purity to be 
used directly (about 80%). All peptides were freeze-dried before fur-
ther use and all peptides were soluble in water (e.g. with concentra-
tions of over 15 mg/ml obtainable for both hydrophobic peptide var-
iants). 
The amino acid sequences of the synthetic peptides are as follows 
(reading from N- to C- terminus). 
(1) Short octa-repeat peptide 
JRYPPQGGGGWGQP#GG 
(2) Long octa-repeat peptide 
i?YPPQG(GGGWGQP/T)4GGGWGQGG 
(3) Met variant of hydrophobic peptide 
.KTNMiOT'MAGAAAAGAVVGGLGGYMLGSAMSi? 
(4) Val variant of hydrophobic peptide 
ATNM^fflvIAGAAAAGAVVGGLGGYVLGSAMSi? 
Highlighted in bold are the residues representing the polymorphism at 
codon 129 in humans and highlighted with italics are those residues 
which contribute to the charge of the peptides. Overall, all the pep-
tides carry a positive charge at neutral pH. 
2.3. Circular dichroism measurements 
2.3.1. Single octa-repeat peptide. Circular dichroism measure-
ments were conducted using a Jasco J600 spectropolarimeter. Sam-
ples of the single-repeat peptide were at 0.5 mg/ml in 50 mM TEA 
buffer containing at least 50 mM acetate at pH 7.4 unless stated 
otherwise. The pH was adjusted using acetic acid or sodium hydrox-
ide. A cell of path length 0.5 mm was used except where stated other-
wise. Scans were conducted between 190 and 260 nm at a scan speed 
of lOnm/min with a sensitivity of 10 mdeg. The temperature was 
measured to an accuracy of ±2° with a probe directly inserted in 
the sample. 
2.3.2. Long octa-repeat peptide and hydrophobic peptides. Circular 
dichroism studies were performed using a Jobin-Yvon CD6 spectro-
polarimeter. Typically data were collected in a 1 mm path length cell 
containing 0.2 mg/ml peptide dissolved in water or in a 0.5 mm path 
length cell with a protein concentration of 0.4 mg/ml. Scans were 
conducted at a resolution of 0.2 nm with an integration time per 
step of 1 s unless stated otherwise. 
2.3.3. Fluorescence studies. Fluorescence work was performed on 
a Spex FluoroMax spectrofluorimeter. Fluorescence emission scans 
were conducted using an excitation wavelength of 278 nm. The pep-
tide concentration used was 0.025 mg/ml. The measurements were 
conducted either in water or 50 mM triethanolamine hydrochloride/ 
50 mM acetate buffer pH 6.0. 
2.3.4. Preparation of phospholipid vesicles. Phosphatidylcholine 
(PC) and phosphatidylserine (PS) were mixed in the ratio 1:4 PS to 
PC. 20 mg of lipid (concentration deduced from product details) were 
taken and the solvent removed firstly by flushing with N2 gas and 
then by desiccation under vacuum (for 10 min). The lipid was resus-
pended in 1 ml of water and the mixture sonicated for 5 X10 s using a 
microtip at 75% of the maximum power for that tip or until the milky 
solution became clearer and opalescent. The vesicle suspension was 
spun at 13 500 rpm in a microfuge for 2 min to remove larger particles 
and stored at 4°C. 
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Fig. 2. A: Circular dichroism spectra of the short octa-repeat pep-
tide showing the effect of temperature on the spectrum. The peptide 
concentration was 0.5 mg/ml and the cell was of path length 0.5 
mm. All samples were dissolved in 50 mM TEA and 50 mM acetate 
pH 7.4. The temperatures were (highest peak) 24.6°, 33.9°, 44.0°, 
53.9°, 61.7°, 70.4°, and 79.1°C (lowest peak). Inset: Spectrum of 
short octa-repeat peptide in water alone. The peptide concentration 
was 0.4 mg/ml and the cell path length was 0.5 mm. The axis labels 
are identical to those in the main diagram. B: Cryogenic spectra of 
single repeat peptide in ethanediol:water mixture (2:1). The peptide 
concentration was 0.5 mg/ml and the cell was of path length 0.5 
mm. The temperature for each spectrum is as follows (highest 
peak): -91.3°, -78.5°, -68.1°, -57.4°, -48.7°, -32.3°, -22.8°, 
19.4°, -13.1° and -3.1°C (lowest peak). The units of delta epsilon 
are cm-1 mol-1. 
3. Results 
3.1. Circular dichroism studies on the single and full-length 
octa-repeat peptides 
3.1.1. Aqueous conditions. Fig. 2A shows CD spectra giv-
en by the 16-residue octa-repeat peptide in buffer at pH 7.4 
with inset showing the spectrum in water. Interestingly the 
short peptide (of 16 residues) gives a distinctive CD spectrum 
which is highly unusual for a short peptide at room temper-
ature. The shape of the curve is unlike any CD spectra char-
acteristic of oc-helix, P-sheet or random coil secondary struc-
ture. There is a broad maximum between 225 and 230 nm 
which decreases towards 210 nm in water, and there is a 
minimum at around 202 nm. Fig. 3 shows the CD spectrum 
of the full-length (46-residue) octa-repeat peptide in water at 
room temperature. It too has a broad maximum peak between 
225 and 230 nm with a trough between 202 and 207 nm. 
Comparison of spectra of the long octa-repeat peptide taken 
at 0.4 mg/ml in 0.5 mm path length cell and 0.02 mg/ml in a 
10 mm path length cell in water showed no concentration 
dependence of this CD signal within experimental error, sug-
gesting no alteration in conformation as a result of associa-
tion of the peptide (data not shown). 
Raising the temperature resulted in a decrease in the peak 
at 228 nm for both peptides which gave a spectrum more 
similar to a random coil conformation (Figs. 2A and 3). In 
both peptides the peak shifted 2 or 3 nm towards longer wave-
lengths. The peak at 228 nm was restored on cooling the short 
peptide to room temperature. 
Cooling the shorter peptide to cryogenic temperatures (Fig. 
2B) in an ethanediol/water mixture (2:1) caused the peak at 
228 to become more intense and to shift to a lower wave-
length (225 nm). The effect of cryogenic temperatures on 
this conformation was fully reversed when the sample re-
turned to room temperature. The large increase in signal at 
low temperature shows that only a small proportion of the 
conformation detected is present at room temperature and 
even at the lowest temperature (—91 °C) the increase had not 
reached its end-point. 
The data given in Figs. 2 and 3 suggest that both peptides 
adopt some kind of non-random conformation which can be 
melted out at higher temperatures and (in the case of the 
shorter peptide) stabilised by cooling. We next added the pro-
tein denaturants, urea and guanidine hydrochloride, to the 
shorter peptide to determine whether this conformation could 
be denatured. Interestingly (see Fig. 4A) these agents induced 
an increase rather than a decrease in the signal at 228 nm 
implying that such a conformation was stabilised by the ac-
tion of these chaotropic agents. This in turn suggests an un-
usually extended conformation. Varying the pH between 4 and 
8 did not significantly affect the spectrum of the shorter pep-
tide. Spectra of the long octa-repeat in 20 mM TEA/20 mM 
acetate buffer at pH 4 and pH 8 showed that the maximum at 
around 228 nm was reduced by a small amount at pH 8 
compared to pH 4 while the minimum at around 202 nm 
was slightly raised at pH 8 compared to that at pH 4 (data 
200 220 240 260 
Wavelength (nm) 
Fig. 3. Effect of temperature on the long octa-repeat peptide. The 
spectra were obtained at 20, 40, 60 and 80°C. The peptide concen-
tration was 0.4 mg/ml and the cell was of path length 0.5 mm. The 
spectra collected were the result of 20 accumulated scans at a reso-
lution of 0.2 nm with an integration time of 1 s. The units of delta 
epsilon are cm-1 mol-1. 
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not shown). The four histidine residues present in this peptide 
could explain this observation which suggests that their pro-
tonation has a weak stabilising effect on the conformation of 
the long octa-repeat peptide. 
3.1.2. Effect of non-polar solvents. In view of the impor-
tance of a conformational change in prion pathogenesis we 
decided to investigate the possibility that a second conforma-
tion is available to the octa-repeat region. We investigated the 
effect of more hydrophobic solvents on the conformation of 
the single repeat peptide. Fig. 4B shows the effect of the sol-
vents, n-propanol, trifluoroethanol and acetonitrile on the CD 
spectrum of the 16-residue octa-repeat. These solvents caused 
a reduction in the intensity of the positive CD signal at 
around 228 nm and an increase in the negative CD signal at 
approximately 202 nm. It is worthy of note that 100% trifluo-
roethanol does not induce oc-helix in this peptide. In acetoni-
trile the spectrum contains two weak maxima at around 209 
and 232 nm, the minimum between occurring at 217 nm. The 
spectrum does not resemble spectra given by any one type of 
secondary structure [45^18] nor is it close to spectra generally 
seen for proteins. Of the standard spectra, those for various 
types of |3-turn [47] and the type I poly-L-proline [45] spectra 
B 
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Fig. 4. A: The effect of chemical denaturants on the CD spectrum 
of the single repeat peptide. A is recorded in 50 mM TEA/50 mM 
acetate buffer pH 7.4 alone, B in 8 M guanidine hydrochloride dis-
solved in the same buffer and C in 10 M urea dissolved in the same 
buffer. B: Circular dichroism spectra of single-repeat peptide in or-
ganic solvents. 1 is 98% acetonitrile (in water), 2 100% w-propanol 
and 3 100% trifluoroethanol. The units of delta epsilon are cm-1 
mol-1. 
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Fig. 5. A: Acetonitrile/water titration of single octa-repeat peptide. 
The acetonitrile concentrations (from 1 to 2) were 95, 90, 80, 70, 
60, 50, 40, 30, 20, 9 and 0% (v/v acetonitrile/water). The peptide 
concentration was 0.4 mg/ml and the cell was of path length 0.5 
mm. B: Circular dichroism of long octa-repeat peptide. The graph 
shows an acetonitrile titration with concentrations of 0, 20, 40, 60, 
70, 80 and 90% acetonitrile in water (v/v). A indicates the 0% aceto-
nitrile spectrum (shown in bold print) and B the 90% acetonitrile 
spectrum (shown in bold print). The cell was of path length 1 mm 
and the peptide concentration was 0.2 mg/ml. Spectra were recorded 
at 25°C and displayed as a spline fit for clarity. The units of delta 
epsilon are cm-1 mol-1. 
have a strong maximum at around 202-206 nm and at 215 nm 
respectively. These features could explain the development of 
a maximum at 209 nm in the octa-repeat peptide. The aceto-
nitrile titration (Fig. 5A) of the peptide exhibited an isodi-
chroic point at around 215 nm which indicates an equilibrium 
between two conformational states. The effect of acetonitrile 
therefore appears to be to stabilise an alternative conforma-
tion to that present in aqueous solution. 
Fig. 5B also shows the CD spectrum of the full-length (46-
residue) octa-repeat peptide in water/acetonitrile mixtures. 
The spectrum given by the longer peptide in water is similar 
to that given by the shorter octa-repeat peptide. The effect of 
acetonitrile in the full-length octa-repeat peptide resembles the 
titration using the single octa-repeat peptide in that a peak at 
around 210 nm can be seen to develop as the concentration of 
acetonitrile increases. 
3.2. Interaction of full-length octa-repeat peptide with vesicles 
Since PrP c is a membrane-anchored protein we investigated 
the interaction of the longer peptide with membranes. To this 
end we used phospholipid vesicles as a simple analogue of a 
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Fig. 6. A: Fluorescence (arbitrary units) emission spectra of long 
octa-repeat peptide in the presence of phospholipid vesicles. The ex-
citation wavelength was 278 nm and the peptide concentration was 
0.025 mg/ml. A is the emission spectrum of peptide alone, B is the 
corrected spectrum in the presence of 10 ul (approx 0.1 mg/ml) of 
the PS/PC vesicle suspension whilst C is the emission spectrum with 
20 ul of vesicle suspension at which the effect saturates. B: Circular 
dichroism spectra of long octa-repeat peptide in the absence (A) 
and presence (B) of vesicles containing phosphatidylcholine and 
phosphatidylserine. A is the spectrum given by 0.2 mg/ml peptide 
with the water baseline subtracted. B is given by the same concen-
tration of peptide in the presence of 30 ul PS/PC vesicles (approx 
2 mg/ml) with the vesicle background subtracted. The spectra col-
lected were the result of 5 accumulated scans at a resolution of 0.2 
nm with an integration time of 1 s. The units of delta epsilon are 
cm-1 mol~l. 
cell membrane. We added phospholipid vesicles containing 
20% phosphatidylserine and 80% phosphatidylcholine to the 
46-residue octa-repeat and obtained a saturable enhancement 
of fluorescence emission intensity, the peak of which was blue-
shifted from 357 nm to 345 nm (see Fig. 6A). The blue shift 
observed on binding is indicative of a change in the environ-
ment of the tryptophan residues within the peptide from 
highly aqueous surroundings to a more hydrophobic environ-
ment. The effect was most marked in water at below neutral 
pH. In buffered solutions the higher ionic strength weakened 
the binding; in 20 mM TEA no binding was observed at pH 
7.4. In buffer at pH 6 (which contained 50 mM TEA and 50 
mM sodium acetate) binding was observed, with an associated 
smaller fluorescence blue shift and smaller enhancement of 
fluorescence. Binding could not be demonstrated with vesicles 
containing only phosphatidylcholine. Hence the 46-residue 
octa-repeat binds to phosphatidylserine in vesicles at below 
neutral pH and low ionic strength. Since phosphatidylcholine 
is neutral and phosphatidylserine is negatively charged it 
seems likely that this binding is aided by a charge interaction 
dependent on protonation of the four histidine residues 
present in this peptide. 
Fig. 6B shows the effect of phospholipid vesicles containing 
phosphatidylcholine and phosphatidylserine on the conforma-
tion of the long octa-repeat peptide under conditions in which 
vesicles have been shown to bind. Both spectra are corrected 
for the background effects of vesicles and water. Addition of 
vesicles causes the spectrum to alter significantly, implying 
that a conformational change is induced. These data do not 
permit full interpretation of the structure but it is interesting 
to note that this spectrum has similar characteristics to that 
obtained with the hydrophobic solvent, acetonitrile. 
3.3. The hydrophobic polypeptide corresponding to residues 
106-136 
CD spectra of both variants of the hydrophobic peptide in 
water were characteristic of a structureless peptide (see Fig. 7) 
with a minimum at around 197 nm and no evidence of mini-
ma between 210 and 250 nm which might imply the presence 
of oc-helix or P-sheet. In 1% SDS the CD spectra suggested a 
proportion of oc-helical content (see Fig. 7) displaying two 
minima at around 207 and 220 nm and a maximum at around 
192 nm. 
In order to determine the effect of the presence of methio-
nine or valine at codon 129 on the conformation of the 'hy-
drophobic' peptides made for this study we obtained CD 
spectra for each peptide in water and in 1% SDS (which in-
duces helix formation and provides a membrane-like environ-
ment). Spectra were identical within the limits of experimental 
error allowing us to conclude that the difference in amino acid 
sequence did not affect the conformation adopted by the pep-
tides as detected by circular dichroism. 
Since it is thought that this region of the protein may be 
involved in dimerisation we mixed the two variants in a ratio 
z 
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Fig. 7. Hydrophobic peptide 106-136 spectra overlaid to show their 
similarity. A: Spectra obtained in water for 0.4 mg/ml of the me-
thionine variant of the hydrophobic peptide 106-136 alone, the val-
ine variant of the peptide alone and a 1:1 mixture of the methio-
nine and valine variants (containing 0.2 mg/ml of methionine 
variant and 0.2 mg/ml of valine variant). B: The same spectra as A 
but in this case 1% SDS in water was used as the solvent. The cell 
was of path length 0.5 mm in all cases. Spectra were collected at a 
resolution of 0.2 nm with an integration time of 2 s. The units of 
delta epsilon are cm-1 mol-1. 
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of 1:1 and compared the resulting spectra both in water and 
1% SDS. Again the spectra were identical within experimental 
error to those obtained for unmixed peptide. 
We also investigated the concentration dependence of the 
shape of the spectra of these peptides in water by taking 
measurements at a concentration of 0.4 mg/ml in a 0.5 mm 
path length cell and 0.02 mg/ml in a 10 mm path length cell. 
There was no significant effect of this 20-fold difference in 
concentration on the shape of the spectrum of either the me-
thionine variant of the valine variant in water implying that 
association or dissociation of the peptide chains either did not 
occur or did not affect their conformation (data not shown). 
Spectra of each of these peptides obtained in buffer (20 mM 
TEA, 20 mM acetate) at pH 4 and pH 8 at 0.4 mg/ml in a 0.5 
mm cell also showed no significant variation within experi-
mental error. 
4. Discussion 
4.1. Octa-repeat peptides 
Although a solution structure for a core section of mouse 
PrP [27] has now been determined this does not include the N-
terminal octa-repeat region of the protein. While we do not 
present a determination of the structure of this region these 
data provide some clues to its nature. It is interesting to note 
that the spectra we have obtained strongly resemble spectra 
obtained for a poly-L-proline type II left-handed extended 
helix [49] which has a minimum at 207 nm and a weak broad 
maximum at 227 nm (our results for the long octa-repeat 
peptide show a minimum between 202 and 207 nm and a 
weak broad maximum between 225 and 230 nm). Our spectra 
are also very similar to those obtained by Tathamet al. [50] 
who suggest that a peptide corresponding to a repeating re-
gion within the protein C hordein and C hordein itself can 
adopt the poly-proline type II helix at low temperature. The 
sequence of the C hordein repeat does contain proline but also 
has glutamine and phenylalanine. Our sequence is not rich in 
proline but there is a high content of glycine and a similar 
collagen-like structure has been reported for poly-glycine pep-
tides [51]. Unfortunately, NMR studies carried out by us to 
confirm the presence of this conformation were complicated 
by the presence of overlapping glycine resonances. However, 
the CD spectra of both long and short octa-repeat peptides 
are affected by changes in temperature which implies the pres-
ence of a proportion of non-random structure. 
What is striking about this structure is its apparent stabil-
ity. A detectable proportion of the characteristic poly-proline 
type II spectrum is seen at room temperature even with a 
peptide of 16 residues. Where similar spectra have been ob-
served [50] these were obtained only at temperatures lower 
than 0°C. Reassuringly the spectra obtained for the longer 
peptide which corresponds to essentially all the octa-repeat 
region have similar characteristics to those given by the short 
peptide corresponding to only a single repeat. The chaotropic 
agents urea and guanidine hydrochloride, which normally de-
stroy ordered structure by reducing the hydrophobic effect, 
appear to stabilise rather than disrupt the structure of the 
short peptide. Also an environment which is thought to pro-
mote the formation of backbone hydrogen bonds, namely 
100% TFE, causes its spectrum to change to one reminiscent 
of random coil. The fluorescence emission maximum of the 
tryptophan residues in the long peptide is at 357 nm which 
implies a highly solvated environment consistent with an ex-
tended conformation. Whether or not the octa-repeat adopts 
a poly-proline type II left-handed helix these results show the 
peptide to be able to adopt a non-random, extended confor-
mation which is resistant to the formation of helix in trifluo-
roethanol. 
In the less polar environment provided by acetonitrile both 
octa-repeat peptides alter conformation. This suggests that a 
hydrophobic environment may induce a conformational 
change in the octa-repeat region. A further property of the 
longer octa-repeat peptide is its ability to bind to phospholi-
pid vesicles in conditions of low salt and below neutral pH 
with a change in tryptophan fluorescence consistent with its 
protection from the aqueous solvent. The CD spectrum also 
changes for the vesicle-bound peptide implying an accompa-
nying conformational change with binding. 
The ability of the mouse PrP 121-231 domain [27] to fold 
independently implies that the octa repeat is not required for 
stability. Furthermore, since this peptide does not fold in a 
classical way and cannot be induced to fold by trifluoroetha-
nol it is possible that a requirement of this domain is specif-
ically not to fold but to remain extended, perhaps in order to 
promote non-specific binding to a membrane or to other pro-
teins. We know that in chicken the analogous repeat region is 
required for endocytosis [52] of PrP c , a fact which would 
suggest that the repeat region may be involved in binding to 
other proteins. 
The octa-repeat region has no direct homologue in other 
proteins, however, it is interesting to note that the synaptic 
vesicle-associated proteins synapsin I and VAMP-I contain 
repeating sequences rich in glycine, glutamine or proline 
which are thought to have a role in binding to vesicles and 
the cytoskeleton [53-55]. Given the finding [12] that PrP is 
necessary for normal synaptic function and its known local-
isation at the surface of neuronal cells it is possible that these 
repeating sequences, although not directly homologous, share 
a similar function with the octa-repeat region of PrP. 
4.2. The hydrophobic polypeptide corresponding to residues 
106-136 
In order to investigate possible structural effects of the poly-
morphism at codon 129 on disease susceptibility we compared 
the CD spectra of two peptides to the hydrophobic region 
identical but for a single change corresponding to either the 
methionine or the valine variant at codon 129. We chose to 
study a sequence longer than other peptides studied so far 
[56], so as to include the whole 23 amino acid hydrophobic 
sequence flanked by the more hydrophilic surrounding resi-
dues. In this way we hoped to minimise the effects of studying 
the sequence in isolation from the whole protein. Much of this 
region (106-120) is not included in the mouse prion domain 
121-231 NMR structure. 
The structural behaviour of this hydrophobic sequence re-
sembles that of transmembrane helical peptides which become 
helical in SDS and phospholipid vesicles. There are also sim-
ilarities to the behaviour of the shorter peptide (PrP 106-126) 
studied previously [56]. In SDS PrP106-126 adopts an a-hel-
ical conformation while in water a random coil conformation 
dominates the spectrum (around 60%). There is a difference, 
however, in that PrP 106-126 in water does possess a propor-
tion of secondary structure(around 13% a-helix and around 
20% P-sheet) while our peptide (corresponding to residues 
384 C.J. Smith et al./FEBS Letters 405 (1997) 378-384 
106-136) gives no strong indication of adopting ordered sec-
ondary structure in water. 
It might be expected that the possibility of an interaction 
between P r P c and PrPS c in the region of codon 129 would be 
reflected in differences in the structural behaviour of the two 
peptides containing this change. This turns out not to be the 
case. Comparing the spectra of the methionine and valine 
peptide variants shows no effect within experimental error 
of the substitution on the conformation of the peptides either 
in SDS or in water. Mixing these peptides or carrying out 
measurements at different concentrations provided no evi-
dence for self-association or dissociation which might influ-
ence conformation under these conditions. 
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